Sunrest Lifescience Ltd Financials

Sunrest Lifescience Ltd Financial Statement

Sunrest Lifescience Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2023	Jun 2023	Mar 2023
Revenue	6.84	5.64	6.87
Operating Expense	6.19	4.63	7.16
Net Profit	1.23	0.75	-0.32
Net Profit Margin	17.98	13.30	-4.66
Earning Per Share	4.12	2.50	TBA
EBIDTA	0.65	1	-0.27
Effective Tax Rate	-93.85	22	7.14

Particulars	Sep 2023
Revenue	6.84
Operating Expense	6.19
Net Profit	1.23
Net Profit Margin	17.98
Earning Per Share	4.12
EBIDTA	0.65
Effective Tax Rate	-93.85

Sunrest Lifescience Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	29.48	24.64	26.89
Operating Expenses Annual	28.58	21.74	25.78
Operating Profit Annual	0.91	2.93	1.13
Interest Annual	0.22	0.06	0.02
Depreciation	0.10	0.13	0.06
Net Profit Annual	0.23	2.04	0.78
Tax Annual	0.37	0.70	0.27

Particulars	Mar 2024
Total Revenue Annual	29.48
Operating Expenses Annual	28.58
Operating Profit Annual	0.91
Interest Annual	0.22
Depreciation	0.10
Net Profit Annual	0.23
Tax Annual	0.37

Sunrest Lifescience Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.45	0.48	0.37
Cash Flow from Operations	-14.80	1.15	-0.44
Cash Flow from Investing	-0.01	-0.03	-0.36
Cash Flow from Financing	14.64	-1.15	0.90
Cash Flow at the End	0.29	0.45	0.48

Particulars	Mar 2024
Cash Flow at the Beginning	0.45
Cash Flow from Operations	-14.80
Cash Flow from Investing	-0.01
Cash Flow from Financing	14.64
Cash Flow at the End	0.29

Sunrest Lifescience Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	3.09	11.89	4.20
PBIT Margin (%)	2.75	11.36	3.98
PBT Margin (%)	-9.90	-178.05	-194.98
Net PROFIT Margin (%)	0.78	8.28	2.90
Return On Networth / Equity (%)	2.66	97.61	114.71
Return On Networth /Employed (%)	6.41	58.58	30.92
Return On Assets (%)	1.79	42.64	22.54
Total Debt / Equity (X)	0.48	1.29	4.09
Asset Turnover Ratio (%)	2.30	5.15	7.77

Particulars	Mar 2024
PBDIT Margin (%)	3.09
PBIT Margin (%)	2.75
PBT Margin (%)	-9.90
Net PROFIT Margin (%)	0.78
Return On Networth / Equity (%)	2.66
Return On Networth /Employed (%)	6.41
Return On Assets (%)	1.79
Total Debt / Equity (X)	0.48
Asset Turnover Ratio (%)	2.30

Sunrest Lifescience Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	0.26	0.35	0.47
Total Current Assets Annual	24.83	16.30	12.52
Non Current Assets Annual	0.32	0.41	0.50
Total Shareholders Funds Annual	14.19	3.11	1.07
Total Assets Annual	25.16	16.71	13.02

Particulars	Mar 2024
Fixed Assets Annual	0.26
Total Current Assets Annual	24.83
Non Current Assets Annual	0.32
Total Shareholders Funds Annual	14.19
Total Assets Annual	25.16

Sunrest Lifescience Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Sunrest Lifescience Ltd Financials

As of Apr 22, 2025, Sunrest Lifescience Ltd has a market capitalization of 26.20 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Sunrest Lifescience Ltd is debt-free with a debt-to-equity ratio of 0.43.

In FY 2024 , Sunrest Lifescience Ltd recorded a total revenue of approximately 29.48 Cr marking a significant milestone in the company's financial performance.

Sunrest Lifescience Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.0% annually, respectively..

Sunrest Lifescience Ltd's current PE ratio is 113.91.

Sunrest Lifescience Ltd's ROCE averaged 27.3% from the FY ending March 2022 to 2024, with a median of 24.6%. It peaked at 53.3% in March 2023, reflecting strong capital efficiency over the period..

Sunrest Lifescience Ltd's latest EBIT is Rs. 0.81 Cr, surpassing the average EBIT of Rs. 1.56 Cr over the 5 years..